Remote Monitoring of COVID-19 Patients Using Multisensor Body Area Network Innovative System.

As of late 2019, the COVID19 pandemic has been causing huge concern around the world. Such a pandemic posed serious threats to public safety, the well-being of healthcare workers, and the overall health of the population. If automation can be implemented in healthcare systems, patients could be better cared for and health industries could be less burdened. To combat such challenges, e-health requires apps and intelligent systems. Using WBAN sensors and networks, a doctor or medical professional can advise patients on the best course of action. Patients' fitness could be assessed using WBAN sensors without interfering with their daily activities. When designing a monitoring system, system performance reliability for competent healthcare is critical. Existing research has failed to create a large device capable of handling a large network or to improve WBAN topologies for fast transmitting and receiving patient data. As a result, in this research, we create a multisensor WBAN (MSWBAN) intelligent system for transmitting and receiving critical patient data. To gather information from all cluster nodes and send it to multisensor WBAN, a novel additive distance-threshold routing protocol (ADTRP) is proposed. In small networks where data are managed by the transmitting node and the best data route is determined, this protocol has less redundancy. An edge-cutting-based routing optimization (ES-EC-R ES-EC-RO) is used to find the best route. The Trouped blowfish MD5 (TB-MD5) algorithm is used to encrypt and decrypt data, and the encrypted data are stored in a cloud database for security. The performance metrics of our proposed model are compared to current techniques for the best results. End-to-end latency is 63 ms, packet delivery is 95%, security is 95.7%, and throughput is 9120 bps, according to the results. The purpose of this article is to encourage engineers and front-line workers to develop digital health systems for tracking and controlling virus outbreaks.

Machine Learning Based Healthcare System for Investigating the Association Between Depression and Quality of Life.

New technological innovations are changing the future of healthcare system. Identification of factors that are responsible for causing depression may lead to new experiments and treatments. Because depression as a disease is becoming a leading community health concern worldwide. Using machine learning techniques this article presents a complete methodological framework to process and explore the heterogenous data and to better understand the association between factors related to quality of life and depression. Subsequently, the experimental study is mainly divided into two parts. In the first part, a data consolidation process is presented. The relationship of data is formed and to uniquely identify each relation in data the concept of the Secure Hash Algorithm is adopted. Hashing is used to locate and index the actual items in the data. The second part proposed a model using both unsupervised and supervised machine learning techniques. The consolidation approach helped in providing a base for formulation and validation of the research hypothesis. The Self organizing map provided 08 cluster solution and the classification problems were taken from the clustered data to further validate the performance of the posterior probability multi-class Support Vector Machine. The expectations of the importance sampling resulted in factors responsible for causing depression. The proposed model was adopted to improve the classification performance, and the result showed classification accuracy of 91.16%.

Li-Pos: A Light Positioning Framework Leveraging OFDM for Visible Light Communication.

The design of solid-state lighting is vital, as numerous metrics are involved in their exact positioning, and as it is utilized in various processes, ranging from intelligent buildings to the internet of things (IoT). This work aims to determine the power and delay spread from the light source to the receiver plane. The positions of the light source and receiver were used for power estimation. We focus on analog orthogonal frequency-division multiplexing (OFDM) in visible light communication (VLC) and assess the area under the curve (AUC). The proposed system was designed using modulation techniques (i.e., quadrature amplitude modulation; QAM) for visible light communication (VLC) and pulse-width modulation (PWM) for dimming sources. For the positioning and spreading of brightness, the proof-of-concept was weighted equally over the entire area. Therefore, the receiver plane was analyzed, in order to measure the power of each light-emitting diode (LED) in a given area, using the delayed mean square error (MSE). A framework was applied for the placement of LEDs, using full-width at half-maximum (FWHM) parameters with varying distances. Then, the received power was confirmed. The results show that the AUC using DRMS values for LEDs significantly increased (by 30%) when the number of source LEDs was changed from four to three. These results confirm that our system, associated with the simple linear lateration estimator, can achieve better energy consumption.

High-dose Oral Ambroxol for Early Treatment of Pulmonary Acute Respiratory Distress Syndrome: an Exploratory, Randomized, Controlled Pilot Trial.

OBJECTIVE: To evaluate efficacy of high-dose oral ambroxol in acute respiratory distress syndrome (ARDS) with respect to ventilator-free days (VFD). DESIGN: Prospective, randomized, placebo-controlled, blinded pilot trial. PATIENTS: Sixty-six mechanically ventilated patients (1 month to 12 years) with ARDS who were hand-ventilated for <24 hr before pediatric intensive care unit admission. INTERVENTIONS: Patients randomized to oral ambroxol (40 mg/kg/day, in four divided doses) (n = 32) or placebo (n = 34) until 10 days, extubation or death whichever is earlier. MEASUREMENTS AND MAIN RESULTS: Majority (91%) had pneumonia and bronchiolitis. Two study groups were similar in baseline characteristics. Mean partial pressure of arterial oxygen/fraction of inspired oxygen and oxygenation index were >175 and <10, respectively, with no difference in the two study groups. VFD were similar in the two study groups. Overall mortality was 26%. No adverse events were noted with ambroxol. CONCLUSIONS: Among ventilated pulmonary ARDS patients with oxygenation index of <10, mortality was 26%. Ambroxol did not improve VFD. Study with higher and more frequently administered doses of ambroxol in larger sample is suggested after having generated relevant pharmacokinetic data among critically ill children.